11 May 2022
On Target Laboratories, Inc. Announces Presentation of the Results from the ELUCIDATE Phase 3 Trial for CYTALUX™ (pafolacianine) injection for Intraoperative Molecular Imaging of Lung Cancer
29 November 2021
FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
14 March 2018
On Target Laboratories Raises Additional Capital from H.I.G. BioHealth Partners, Elevate Ventures and Helsinn
Thank you for your form submission, we will get in contact with you shortly.